TY - JOUR
T1 - Plk1-mediated phosphorylation of topors regulates p53 stability
AU - Yang, Xiaoming
AU - Li, Hongchang
AU - Zhou, Zinan
AU - Wang, Wen Horng
AU - Deng, Anping
AU - Andrisani, Ourania
AU - Liu, Xiaoqi
PY - 2009/7/10
Y1 - 2009/7/10
N2 - Polo-like kinase 1 (Plk1) overexpression is associated with tumorigenesis by an unknown mechanism. Likewise, Plk1 was suggested to act as a negative regulator of tumor suppressor p53, but the mechanism remains to be determined. Herein, we have identified topoisomerase I-binding protein (Topors), a p53-binding protein, as a Plk1 target. We show that Plk1 phosphorylates Topors on Ser718 in vivo. Significantly, expression of a Plk1-unphosphorylatable Topors mutant (S718A) leads to a dramatic accumulation of p53 through inhibition of p53 degradation. Topors is an ubiquitin and small ubiquitin-like modifier ubiquitin-protein isopeptide ligase (SUMO E3) ligase. Plk1-mediated phosphorylation of Topors inhibits Topors-mediated sumoylation of p53, whereas p53 ubiquitination is enhanced, leading to p53 degradation. These results demonstrate that Plk1 modulates Topors activity in suppressing p53 function and identify a likely mechanism for the tumorigenic potential of Plk1.
AB - Polo-like kinase 1 (Plk1) overexpression is associated with tumorigenesis by an unknown mechanism. Likewise, Plk1 was suggested to act as a negative regulator of tumor suppressor p53, but the mechanism remains to be determined. Herein, we have identified topoisomerase I-binding protein (Topors), a p53-binding protein, as a Plk1 target. We show that Plk1 phosphorylates Topors on Ser718 in vivo. Significantly, expression of a Plk1-unphosphorylatable Topors mutant (S718A) leads to a dramatic accumulation of p53 through inhibition of p53 degradation. Topors is an ubiquitin and small ubiquitin-like modifier ubiquitin-protein isopeptide ligase (SUMO E3) ligase. Plk1-mediated phosphorylation of Topors inhibits Topors-mediated sumoylation of p53, whereas p53 ubiquitination is enhanced, leading to p53 degradation. These results demonstrate that Plk1 modulates Topors activity in suppressing p53 function and identify a likely mechanism for the tumorigenic potential of Plk1.
UR - http://www.scopus.com/inward/record.url?scp=67650529837&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=67650529837&partnerID=8YFLogxK
U2 - 10.1074/jbc.C109.001560
DO - 10.1074/jbc.C109.001560
M3 - Article
C2 - 19473992
AN - SCOPUS:67650529837
SN - 0021-9258
VL - 284
SP - 18588
EP - 18592
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 28
ER -